Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

DETECT: Defining the Target Volume for Endoluminal Radiation Boosting in Patients With Rectal Cancer

NCT04927897 is registered in ClinicalTrials.gov with Maastricht Radiation Oncology as lead sponsor.

NCT NCT04927897
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04927897 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
DETECT: Defining the Target Volume for Endoluminal Radiation Boosting in Patients With Rectal Cancer
Lead sponsor
Maastricht Radiation Oncology
Phase
Observational
Overall status
Recruiting
Start date
August 16, 2022
Completion date
December 31, 2027
Enrollment
50 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

rectal cancer